QA: Immuneering Corp in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001790340_2026_Immuneering_Corp.pdf

Logs

Graph

Absolute values for 0001790340, Immuneering Corp

  xvar xval
0 AssetsCurrent 176,245,954
1 IntangibleAssetsNetIncludingGoodwill 7,011,578
2 PropertyPlantAndEquipmentNet 938,481
3 remainder_Assets 47,788,997
4 LiabilitiesCurrent 10,073,721
5 LiabilitiesNoncurrent 3,427,321
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,686,732
9 ResearchAndDevelopmentExpense 38,833,230
10 remainder_Expenses 29,267
11 remainder_Revenues 0
12 remainder_NetIncome 3,304,893
13 remainder_ComprehensiveNetIncome 45,459
  yvar yval
0 Assets 231,985,010
1 Liabilities 13,501,042
2 Expenses 57,549,229
3 Revenues 0
4 StockholdersEquity 218,483,968
5 NetIncome -54,244,336
6 ComprehensiveNetIncome -54,221,606
7 BaseVar 153,192,816
8 EconomicCapitalRatiobeforeLimitedLiability 3.44
9 EconomicCapitalRatio 3.99

Edgar->Model Mapping

Feature Distribution

Change over Time